Scientists from the Helmholtz Zentrum München in cooperation with the University of Cincinnati, USA, have discovered that the placement of a non-permeable tube in the small intestine leads to reduced nutrient absorption and consequently to reduced obesity and enhanced glucose metabolism. These findings are published in the current issue of the British medical journal Gut.
Bariatric surgeries, such as a gastric bypass, are currently the most effective anti-obesity therapies. They also lead to a reduced insulin resistance. However, the pitfall of these surgical interventions is that they are highly invasive and often permanent procedures. An international team of scientists led by Dr. Kirk Habegger, Metabolic Disease Institute, University of Cincinnati, and Prof. Dr. Matthias Tschöp, Scientific Director of the Helmholtz Diabetes Center (HDC) at the Helmholtz Zentrum München (HMGU), Partner of the German Center for Diabetes Research (DZD), have now developed an equally efficient but less invasive surgical method, thus paving the way for the development of novel safe and efficient anti-obesity therapies.
In their study, a flexible tube, called a DES (duodenal-endoluminal sleeve), was placed in the small intestine. Tschöp, Habegger, and colleagues observed that this intervention in an animal model potently corrects obesity while improving glucose metabolism. The metabolic benefits of this novel surgical intervention seem to be mediated via reduced nutrient absorption in the intestinal lumen and reactive mucous membrane growth in the other intestinal sections, a shift which may lead to improved nutrient utilization. The intervention carries the great advantage that it is less invasive and removable at any time.
The method is consequently seen as a promising approach to treat obesity and diabetes. Further studies now aim to clarify which influence this novel surgical technique has on the complex neuroendocrine network that controls energy metabolism. The long-term goal based on such better understanding is to optimize devices to the level where they can be used successfully in humans, potentially in combination with hormone based drug therapies. (Also see press release "Enhancing weight loss: Gastric banding with hormone therapy")
The numerous conditions associated with overweight and obesity, such as type 2 diabetes, are among the major widespread diseases in Germany. They are the focus of the research at the Helmholtz Zentrum München.
Explore further: Adjustable gastric banding more effective when combined with gastrointestinal hormone GLP-1
More information: Habegger, K. et al (2013). Duodenal Nutrient Exclusion Improves Metabolic Syndrome and Stimulates Villus Hyperplasia, Gut. DOI: 10.1136/gutjnl-2013-304583
Medical Xpress on facebook
Related Stories
Adjustable gastric banding more effective when combined with gastrointestinal hormone GLP-1
Jun 20, 2013
Pharmacological activation of the receptor for glucagon-like peptide 1 (GLP-1) in conjunction with adjustable gastric banding (AGB) surgery may improve weight loss outcomes achieved with this procedure when ...
Study explains why diabetic retinopathy is difficult to treat
Oct 07, 2013
Damage to the retina due to diabetes can be ameliorated only partially, despite treatment with the standard drug metformin. Scientists of Helmholtz Zentrum München have discovered that metformin treatment normalizes the ...
Doubling down against diabetes: Turbo-charged gut hormones
Nov 13, 2012
A collaboration between scientists in Munich, Germany and Bloomington, USA may have overcome one of the major challenges drug makers have struggled with for years: Delivering powerful nuclear hormones to specific tissues, ...
Body weight influences both the physical and mental quality of life
Sep 03, 2013
Body weight has a great influence on our quality of life. While physical health deteriorates when weight is gained, mental well-being seems to improve, especially in women. This has been reported by scientists from the Helmholtz ...
Study finds possible alternative to bariatric weight loss surgery
Apr 30, 2013
An experimental procedure successfully tested in obese laboratory rats may provide a less-invasive alternative to bariatric weight-loss surgery, researchers report online in Endocrinology.
Recommended for you
Re-writing the research on the treatment of infection
2 hours ago
(Medical Xpress)—A major breakthrough in the search for alternatives to antibiotics and the treatment of infection could provide microbiologists with a whole new insight into the way germs co-exist with ...
Scientist looks at eating patterns, biological clocks
3 hours ago
When you eat could have as much impact on your health as what you eat. That's the conclusion reached by researchers in an ongoing series of papers and studies funded as part of a major grant from the National ...
Lab mice breakthrough offers Alzheimer's hope (Update)
4 hours ago
Scientists on Thursday said they had tested a drug that in mice prevented the death of brain cells, boosting hopes in the fight against Alzheimer's, Parkinson's and other neurodegenerative diseases.
Using stem cells to promote nerve regeneration
19 hours ago
Johns Hopkins researchers from the Department of Plastic and Reconstructive Surgery report that a type of stem cell found easily in fat cells and also in bone marrow promoted nerve regeneration in rats with paralyzing leg ...
Gene and stem cell therapy combination could aid wound healing
19 hours ago
Johns Hopkins researchers, working with elderly mice, have determined that combining gene therapy with an extra boost of the same stem cells the body already uses to repair itself leads to faster healing of burns and greater ...
New strategy lets cochlear implant users hear music
20 hours ago
For many, music is a universal language that unites people when words cannot. But for those who use cochlear implants—technology that allows deaf and hard of hearing people to comprehend speech—hearing ...
User comments
© Medical Xpress 2011-2013, Phys.org network
Scientists from the Helmholtz Zentrum München in cooperation with the University of Cincinnati, USA, have discovered that the placement of a non-permeable tube in the small intestine leads to reduced nutrient absorption and consequently to reduced obesity and enhanced glucose metabolism. These findings are published in the current issue of the British medical journal Gut.
Bariatric surgeries, such as a gastric bypass, are currently the most effective anti-obesity therapies. They also lead to a reduced insulin resistance. However, the pitfall of these surgical interventions is that they are highly invasive and often permanent procedures. An international team of scientists led by Dr. Kirk Habegger, Metabolic Disease Institute, University of Cincinnati, and Prof. Dr. Matthias Tschöp, Scientific Director of the Helmholtz Diabetes Center (HDC) at the Helmholtz Zentrum München (HMGU), Partner of the German Center for Diabetes Research (DZD), have now developed an equally efficient but less invasive surgical method, thus paving the way for the development of novel safe and efficient anti-obesity therapies.
In their study, a flexible tube, called a DES (duodenal-endoluminal sleeve), was placed in the small intestine. Tschöp, Habegger, and colleagues observed that this intervention in an animal model potently corrects obesity while improving glucose metabolism. The metabolic benefits of this novel surgical intervention seem to be mediated via reduced nutrient absorption in the intestinal lumen and reactive mucous membrane growth in the other intestinal sections, a shift which may lead to improved nutrient utilization. The intervention carries the great advantage that it is less invasive and removable at any time.
The method is consequently seen as a promising approach to treat obesity and diabetes. Further studies now aim to clarify which influence this novel surgical technique has on the complex neuroendocrine network that controls energy metabolism. The long-term goal based on such better understanding is to optimize devices to the level where they can be used successfully in humans, potentially in combination with hormone based drug therapies. (Also see press release "Enhancing weight loss: Gastric banding with hormone therapy")
The numerous conditions associated with overweight and obesity, such as type 2 diabetes, are among the major widespread diseases in Germany. They are the focus of the research at the Helmholtz Zentrum München.
Explore further: Adjustable gastric banding more effective when combined with gastrointestinal hormone GLP-1
More information: Habegger, K. et al (2013). Duodenal Nutrient Exclusion Improves Metabolic Syndrome and Stimulates Villus Hyperplasia, Gut. DOI: 10.1136/gutjnl-2013-304583
Medical Xpress on facebook
Related Stories
Adjustable gastric banding more effective when combined with gastrointestinal hormone GLP-1
Jun 20, 2013
Pharmacological activation of the receptor for glucagon-like peptide 1 (GLP-1) in conjunction with adjustable gastric banding (AGB) surgery may improve weight loss outcomes achieved with this procedure when ...
Study explains why diabetic retinopathy is difficult to treat
Oct 07, 2013
Damage to the retina due to diabetes can be ameliorated only partially, despite treatment with the standard drug metformin. Scientists of Helmholtz Zentrum München have discovered that metformin treatment normalizes the ...
Doubling down against diabetes: Turbo-charged gut hormones
Nov 13, 2012
A collaboration between scientists in Munich, Germany and Bloomington, USA may have overcome one of the major challenges drug makers have struggled with for years: Delivering powerful nuclear hormones to specific tissues, ...
Body weight influences both the physical and mental quality of life
Sep 03, 2013
Body weight has a great influence on our quality of life. While physical health deteriorates when weight is gained, mental well-being seems to improve, especially in women. This has been reported by scientists from the Helmholtz ...
Study finds possible alternative to bariatric weight loss surgery
Apr 30, 2013
An experimental procedure successfully tested in obese laboratory rats may provide a less-invasive alternative to bariatric weight-loss surgery, researchers report online in Endocrinology.
Recommended for you
Re-writing the research on the treatment of infection
2 hours ago
(Medical Xpress)—A major breakthrough in the search for alternatives to antibiotics and the treatment of infection could provide microbiologists with a whole new insight into the way germs co-exist with ...
Scientist looks at eating patterns, biological clocks
3 hours ago
When you eat could have as much impact on your health as what you eat. That's the conclusion reached by researchers in an ongoing series of papers and studies funded as part of a major grant from the National ...
Lab mice breakthrough offers Alzheimer's hope (Update)
4 hours ago
Scientists on Thursday said they had tested a drug that in mice prevented the death of brain cells, boosting hopes in the fight against Alzheimer's, Parkinson's and other neurodegenerative diseases.
Using stem cells to promote nerve regeneration
19 hours ago
Johns Hopkins researchers from the Department of Plastic and Reconstructive Surgery report that a type of stem cell found easily in fat cells and also in bone marrow promoted nerve regeneration in rats with paralyzing leg ...
Gene and stem cell therapy combination could aid wound healing
19 hours ago
Johns Hopkins researchers, working with elderly mice, have determined that combining gene therapy with an extra boost of the same stem cells the body already uses to repair itself leads to faster healing of burns and greater ...
New strategy lets cochlear implant users hear music
20 hours ago
For many, music is a universal language that unites people when words cannot. But for those who use cochlear implants—technology that allows deaf and hard of hearing people to comprehend speech—hearing ...
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment